EP Patent
EP2874886B1 — Techniques for manufacturing ingestible event markers comprising an ingestible component
Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2023-12-20 · 2y expired
What this patent protects
Patent listed against Abilify.
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.